🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-center evaluation of Aldafermin (NGM282) in an open-label,...
Status
Completed
Location
NGM Clinical Study Site
Start Date
2019-11-08
Trial ID
NCT04179630
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, and act...
Status
Completed
Location
NGM Clinical Study Site 6103
Start Date
2013-09
Trial ID
NCT01943045
The purpose of this study is to determine the safety, tolerability, and act...
Status
Completed
Location
NGM Clinical Study Site 103
Start Date
2014-05
Trial ID
NCT02135536
Treatments Being Tested
This is an open-label study to assess safety, tolerability, and pharmacokin...
Status
Completed
Location
NGM Clinical Study Site 112
Start Date
2021-04-13
Trial ID
NCT04828265
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, and act...
Status
Completed
Location
NGM Clinical Study Site 103
Start Date
2014-02
Trial ID
NCT02026401
The purpose of this study is to determine the safety and tolerability of NG...
Status
Completed
Location
NGM Clinical Study Site
Start Date
2013-01
Trial ID
NCT01776528
A multi-center evaluation of aldafermin in a randomized, double-blind, plac...
Status
Completed
Location
NGM Clinical Study Site
Start Date
2020-03-23
Trial ID
NCT04210245
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, and act...
Status
Completed
Location
NGM Clinical Study Site 118
Start Date
2016-03
Trial ID
NCT02704364
The purpose of this study is to determine the safety, tolerability, and eff...
Status
Completed
Location
NGM Clinical Study Site 922
Start Date
2015-07-31
Trial ID
NCT02443116
This is an evaluation of Aldafermin (NGM282) in an open-label, single-dose ...
Status
Completed
Location
NGM Clinical Study Site 110
Start Date
2021-04-01
Trial ID
NCT04823702
Treatments Being Tested